AMARYL cpr 4 mg 30 pce
7680531300973
CH-53130
A10BB12
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
glimepiridum
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
135.85 MG | Substance | HBESI |
|
carboxymethylamylum natricum
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
|
povidonum K 25
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
E 132
|
- | Substance | FIMDK |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 53130
- Drug name
- Amaryl, comprimés
- Galenic form
- TAB
- ATC Code
- A10BB12
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 22/06/1995
- Authorization expiration date
- 01/05/2025
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AMARYL cpr 4 mg 30 pce
- Description (DE)
- AMARYL Tabl 4 mg 30 Stk
- Market launch
- 22/06/1995
- Market withdrawal
- 01/05/2025
- Narcotic (BTM)
- No